Network Edge Inference for Large Language Models: Principles, Techniques, and Opportunities
ACM Computing Surveys · 30.09.2026 · 58 (12) · 1-35
DOI: 10.1145/3809166 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACM Computing Surveys, online erschienen am 19.05.2026. Verfasst von Zhixiong Chen und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Large language models (LLMs) have advanced rapidly, emerging as versatile tools across fields thanks to their exceptional language understanding, generation, and reasoning capabilities. However, performing LLM inference at the network edge remains challenging due to their large memory and compute demands. This survey outlines the challenges specific to LLM edge inference and provides a comprehensive overview of recent progress, covering system architectures, model optimization and deployment, and resource management and scheduling. By synthesizing state-of-the-art techniques and mapping future directions, this survey aims to unlock the potential of LLMs in resource-constrained edge environments.
Zitieren
APA
Chen, Z., Zhu, B., Wang, J., Shin, H., Nallanathan, A., & Niyato, D. T. (2026). Network Edge Inference for Large Language Models: Principles, Techniques, and Opportunities. ACM Computing Surveys, 58(12), 1-35. https://doi.org/10.1145/3809166
Vancouver
Chen Z, Zhu B, Wang J, Shin H, Nallanathan A, Niyato DT. Network Edge Inference for Large Language Models: Principles, Techniques, and Opportunities. ACM Computing Surveys. 2026;58(12):1-35. doi:10.1145/3809166
BibTeX
@article{Chen2026,
author = {Chen, Zhixiong and Zhu, Bingjie and Wang, Jiangzhou and Shin, Hyundong and Nallanathan, Arumugam and Niyato, Dusit (Tao)},
title = {Network Edge Inference for Large Language Models: Principles, Techniques, and Opportunities},
journal = {ACM Computing Surveys},
year = {2026},
volume = {58},
number = {12},
pages = {1--35},
doi = {10.1145/3809166}
}
EUVIMED